GlassScriptPhysician profile
Kylan Poullard
NPI 1780268516
$1,386.39
in general payments reported to CMS, 2019-2025
20 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $206 · 2023: $286 · 2024: $212 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $192.44 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ivantis, INC | $163.46 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $151.49 | 2022-2023 | Tecnis Iol |
| Novo Nordisk INC | $125.01 | 2025 | Ozempic |
| Aerie Pharmaceuticals, INC. | $125.00 | 2021 | |
| Abbvie INC. | $96.65 | 2024-2025 | |
| Tandem Diabetes Care, INC. | $77.52 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $59.99 | 2025 | Dexcom G6 Transmitter |
| Ocular Therapeutix, INC. | $50.01 | 2023-2024 | Dextenza |
| Merz Pharmaceuticals, LLC | $49.55 | 2022 | |
| Rxsight INC | $46.42 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Sun Pharmaceutical Industries INC. | $40.90 | 2023-2024 | Cequa |
| Janssen Biotech, INC. | $39.37 | 2024 | Stelara |
| Coopervision INC. | $37.46 | 2022 | |
| Biotissue Holdings INC. | $32.25 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $23.66 | 2022 | |
| Bausch & Lomb Americas INC. | $22.73 | 2023 | Vyzulta, Zylet, Prolensa |
| Dompe US, INC. | $20.53 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $17.33 | 2023 | Tyrvaya |
| Harrow Eye, LLC | $14.62 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kylan Poullard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.